Search research articles
Contact Us
Filters
Showing results (231-240 of 288) with videos related to
Page
of 29
Sort By:
The Journal of Infectious Diseases
|
September 18, 1997
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange
P Bagnarelli, M Candela, A Valenza, et al.
American Journal of Human Genetics
|
January 13, 2000
NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes
P Riva, L Corrado, F Natacci, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 2, 2003
Humoral immune response against hepatitis C virus
R Burioni, N Mancini, F Canducci, et al.
Journal of Hepatology
|
April 1, 1997
Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment
G Ballardini, A Manzin, F Giostra, et al.
Human Molecular Genetics
|
December 15, 2000
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1
M d'Addio, A Pizzigoni, M T Bassi, et al.
AIDS (London, England)
|
July 14, 2000
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy
S Menzo, S Rusconi, A Monachetti, et al.
Liver
|
July 8, 1999
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
G S Baroni, A Pastorelli, A Manzin, et al.
Hepatology (Baltimore, Md.)
|
September 10, 1998
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments
R Burioni, P Plaisant, A Manzin, et al.
Virology
|
September 7, 2001
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs
R Burioni, F Bugli, N Mancini, et al.
AIDS (London, England)
|
August 1, 1997
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
C Balotta, P Bagnarelli, M Violin, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 288) with videos related to
Sort By:
Page
of 29
The Journal of Infectious Diseases
|
September 18, 1997
Dynamic features of human immunodeficiency virus type 1 (HIV-1) viremia: kinetics of cell-free HIV-1 RNA after therapeutic plasma exchange
P Bagnarelli, M Candela, A Valenza, et al.
American Journal of Human Genetics
|
January 13, 2000
NF1 microdeletion syndrome: refined FISH characterization of sporadic and familial deletions with locus-specific probes
P Riva, L Corrado, F Natacci, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 2, 2003
Humoral immune response against hepatitis C virus
R Burioni, N Mancini, F Canducci, et al.
Journal of Hepatology
|
April 1, 1997
Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment
G Ballardini, A Manzin, F Giostra, et al.
Human Molecular Genetics
|
December 15, 2000
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1
M d'Addio, A Pizzigoni, M T Bassi, et al.
AIDS (London, England)
|
July 14, 2000
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy
S Menzo, S Rusconi, A Monachetti, et al.
Liver
|
July 8, 1999
Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C
G S Baroni, A Pastorelli, A Manzin, et al.
Hepatology (Baltimore, Md.)
|
September 10, 1998
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments
R Burioni, P Plaisant, A Manzin, et al.
Virology
|
September 7, 2001
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs
R Burioni, F Bugli, N Mancini, et al.
AIDS (London, England)
|
August 1, 1997
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient
C Balotta, P Bagnarelli, M Violin, et al.
Page
of 29